Consistent with the findings of Yamaguchi et al. [10], we found that ACE2 was frequently overexpressed in mutant EGFR lung adenocarcinomas, which was further supported by a significantly higher sACE2 concentration being found in these patients compared to wild-type EGFR samples. This evidence concerns the gene ACE2 and lung adenocarcinoma.